Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity

Mohamed A. Hussein, David K. Coats, Humair Khan, Evelyn A. Paysse, Paul G. Steinkuller, Lingkun Kong, Smith E. O'Brian

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose To explore the association of autonomic agents with the development and severity of retinopathy of prematurity (ROP). Methods The medical records of all preterm infants screened for ROP were retrospective reviewed. The association between development and severity of ROP and the use and dose(s) of autonomic agents was analyzed, after adjustment for the covariates gestational age, weight, development of septicemia, intraventricular hemorrhage, and respiratory distress syndrome. Results A total of 350 infants were screened. Caffeine was used in 338 infants; dopamine in 98 infants. There was a significant association between the use of dopamine and development of ROP (P < 0.001; relative risk [RR] = 1.6 [95% CI, 1.23-2.06]) and the need for ROP treatment (P = 0.001; RR = 4.63 [95% CI, 1.82-11.79]). The number of dopamine doses was significantly associated with the development of any ROP (P < 0.001; RR = 1.07 [95% CI, 1.03-1.1]), the severity of ROP (P < 0.001; RR = 1.09 [95% CI, 1.05-1.14]), and the need for treatment (P < 0.001; RR = 1.09 [95% CI, 1.05-1.14]). The total dose of caffeine was significantly associated with the development of any ROP (P = 0.003; RR = 1.03 [95% CI, 1.01-1.05]) and the need for treatment (P = 0.006, RR = 1.073 [95% CI; 1.021-1.13]). Conclusions Although a causal relationship was not identified, the use of the autonomic agents caffeine and dopamine was associated with the development and severity of retinopathy of prematurity in this cohort.

Original languageEnglish (US)
Pages (from-to)332-337
Number of pages6
JournalJournal of AAPOS
Volume18
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Autonomic Agents
Retinopathy of Prematurity
Dopamine
Caffeine
Premature Infants
Gestational Age
Medical Records
Sepsis
Therapeutics
Hemorrhage

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Ophthalmology

Cite this

Hussein, M. A., Coats, D. K., Khan, H., Paysse, E. A., Steinkuller, P. G., Kong, L., & O'Brian, S. E. (2014). Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity. Journal of AAPOS, 18(4), 332-337. https://doi.org/10.1016/j.jaapos.2014.02.012

Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity. / Hussein, Mohamed A.; Coats, David K.; Khan, Humair; Paysse, Evelyn A.; Steinkuller, Paul G.; Kong, Lingkun; O'Brian, Smith E.

In: Journal of AAPOS, Vol. 18, No. 4, 2014, p. 332-337.

Research output: Contribution to journalArticle

Hussein, Mohamed A. ; Coats, David K. ; Khan, Humair ; Paysse, Evelyn A. ; Steinkuller, Paul G. ; Kong, Lingkun ; O'Brian, Smith E. / Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity. In: Journal of AAPOS. 2014 ; Vol. 18, No. 4. pp. 332-337.
@article{302b496ef3854251b5ab586491d2ee04,
title = "Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity",
abstract = "Purpose To explore the association of autonomic agents with the development and severity of retinopathy of prematurity (ROP). Methods The medical records of all preterm infants screened for ROP were retrospective reviewed. The association between development and severity of ROP and the use and dose(s) of autonomic agents was analyzed, after adjustment for the covariates gestational age, weight, development of septicemia, intraventricular hemorrhage, and respiratory distress syndrome. Results A total of 350 infants were screened. Caffeine was used in 338 infants; dopamine in 98 infants. There was a significant association between the use of dopamine and development of ROP (P < 0.001; relative risk [RR] = 1.6 [95{\%} CI, 1.23-2.06]) and the need for ROP treatment (P = 0.001; RR = 4.63 [95{\%} CI, 1.82-11.79]). The number of dopamine doses was significantly associated with the development of any ROP (P < 0.001; RR = 1.07 [95{\%} CI, 1.03-1.1]), the severity of ROP (P < 0.001; RR = 1.09 [95{\%} CI, 1.05-1.14]), and the need for treatment (P < 0.001; RR = 1.09 [95{\%} CI, 1.05-1.14]). The total dose of caffeine was significantly associated with the development of any ROP (P = 0.003; RR = 1.03 [95{\%} CI, 1.01-1.05]) and the need for treatment (P = 0.006, RR = 1.073 [95{\%} CI; 1.021-1.13]). Conclusions Although a causal relationship was not identified, the use of the autonomic agents caffeine and dopamine was associated with the development and severity of retinopathy of prematurity in this cohort.",
author = "Hussein, {Mohamed A.} and Coats, {David K.} and Humair Khan and Paysse, {Evelyn A.} and Steinkuller, {Paul G.} and Lingkun Kong and O'Brian, {Smith E.}",
year = "2014",
doi = "10.1016/j.jaapos.2014.02.012",
language = "English (US)",
volume = "18",
pages = "332--337",
journal = "Journal of AAPOS",
issn = "1091-8531",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity

AU - Hussein, Mohamed A.

AU - Coats, David K.

AU - Khan, Humair

AU - Paysse, Evelyn A.

AU - Steinkuller, Paul G.

AU - Kong, Lingkun

AU - O'Brian, Smith E.

PY - 2014

Y1 - 2014

N2 - Purpose To explore the association of autonomic agents with the development and severity of retinopathy of prematurity (ROP). Methods The medical records of all preterm infants screened for ROP were retrospective reviewed. The association between development and severity of ROP and the use and dose(s) of autonomic agents was analyzed, after adjustment for the covariates gestational age, weight, development of septicemia, intraventricular hemorrhage, and respiratory distress syndrome. Results A total of 350 infants were screened. Caffeine was used in 338 infants; dopamine in 98 infants. There was a significant association between the use of dopamine and development of ROP (P < 0.001; relative risk [RR] = 1.6 [95% CI, 1.23-2.06]) and the need for ROP treatment (P = 0.001; RR = 4.63 [95% CI, 1.82-11.79]). The number of dopamine doses was significantly associated with the development of any ROP (P < 0.001; RR = 1.07 [95% CI, 1.03-1.1]), the severity of ROP (P < 0.001; RR = 1.09 [95% CI, 1.05-1.14]), and the need for treatment (P < 0.001; RR = 1.09 [95% CI, 1.05-1.14]). The total dose of caffeine was significantly associated with the development of any ROP (P = 0.003; RR = 1.03 [95% CI, 1.01-1.05]) and the need for treatment (P = 0.006, RR = 1.073 [95% CI; 1.021-1.13]). Conclusions Although a causal relationship was not identified, the use of the autonomic agents caffeine and dopamine was associated with the development and severity of retinopathy of prematurity in this cohort.

AB - Purpose To explore the association of autonomic agents with the development and severity of retinopathy of prematurity (ROP). Methods The medical records of all preterm infants screened for ROP were retrospective reviewed. The association between development and severity of ROP and the use and dose(s) of autonomic agents was analyzed, after adjustment for the covariates gestational age, weight, development of septicemia, intraventricular hemorrhage, and respiratory distress syndrome. Results A total of 350 infants were screened. Caffeine was used in 338 infants; dopamine in 98 infants. There was a significant association between the use of dopamine and development of ROP (P < 0.001; relative risk [RR] = 1.6 [95% CI, 1.23-2.06]) and the need for ROP treatment (P = 0.001; RR = 4.63 [95% CI, 1.82-11.79]). The number of dopamine doses was significantly associated with the development of any ROP (P < 0.001; RR = 1.07 [95% CI, 1.03-1.1]), the severity of ROP (P < 0.001; RR = 1.09 [95% CI, 1.05-1.14]), and the need for treatment (P < 0.001; RR = 1.09 [95% CI, 1.05-1.14]). The total dose of caffeine was significantly associated with the development of any ROP (P = 0.003; RR = 1.03 [95% CI, 1.01-1.05]) and the need for treatment (P = 0.006, RR = 1.073 [95% CI; 1.021-1.13]). Conclusions Although a causal relationship was not identified, the use of the autonomic agents caffeine and dopamine was associated with the development and severity of retinopathy of prematurity in this cohort.

UR - http://www.scopus.com/inward/record.url?scp=84906836924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906836924&partnerID=8YFLogxK

U2 - 10.1016/j.jaapos.2014.02.012

DO - 10.1016/j.jaapos.2014.02.012

M3 - Article

C2 - 25173894

AN - SCOPUS:84906836924

VL - 18

SP - 332

EP - 337

JO - Journal of AAPOS

JF - Journal of AAPOS

SN - 1091-8531

IS - 4

ER -